(Q38312231)

2 September 2017

Effect of DNase on the activity of neutrophil elastase, cathepsin G and proteinase 3 in the presence of DNA. (English)

1 reference

2 September 2017

Duranton J

1

1 reference

2 September 2017

Belorgey D

2

1 reference

2 September 2017

Carrère J

3

1 reference

2 September 2017

Donato L

4

1 reference

2 September 2017

Moritz T

5

1 reference

2 September 2017

Bieth JG

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

2 September 2017

1 reference

2 September 2017

473

1 reference

2 September 2017

2

1 reference

2 September 2017

154-156

1 reference

Serine proteinase inhibitor therapy in alpha(1)-antitrypsin inhibitor deficiency and cystic fibrosis

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

DNA concentration and length in sputum of patients with cystic fibrosis during inhalation with recombinant human DNase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

Effect of nebulised recombinant DNase on neutrophil elastase load in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

Design of potent reversible inhibitors for thermolysin. Peptides containing zinc coordinating ligands and their use in affinity chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

The polymorphonuclear leukocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

Colorimetric determination of DNase I activity with a DNA-methyl green substrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

Inhibition of human leucocyte elastase by polynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

DNA binds neutrophil elastase and mucus proteinase inhibitor and impairs their functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

Aerosolized rhDNase in cystic fibrosis: effect on leucocyte proteases in sputum

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

DNase I acutely increases cystic fibrosis sputum elastase activity and its potential to induce lung hemorrhage in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

Neutrophil proteinases and rhDNase therapy in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2901512-X

10.1016/S0014-5793(00)01512-X

21 January 2018

Identifiers

DOI

1 reference

2 September 2017

1 reference